We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ANDA Approval

News List

Glenmark’s Acyclovir Ointment USP, 5% receives ANDA approval expressbpd
August 03, 2017
Acyclovir Ointment USP, 5 per cent is the generic version of Zovirax Ointment, 5 per cent
Glenmark Receives ANDA Approval for Indomethacin americanpharmaceuticalreview
June 29, 2017
Glenmark Pharmaceuticals has been granted final Abbreviated New Drug Application (ANDA) approval by the United States Food & Drug Administration (U.S. FDA) for Indomethacin Extended-Release Capsules USP, 75 mg,
Breckenridge Announces Final ANDA Approval for Azacitidine for Injection americanpharmaceuticalreview
June 27, 2017
Breckenridge Pharmaceutical announced the FDA has granted final approval of its ANDA Azacitidine for Injection, 100mg per vial, Single-Dose Vial, a generic version of Vidaza by Celgene Corporation.